Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 10, 2017 Filed Apr 12, 2017 20:18 UTC |
McClellan Stephen RPresident, Americas
|
SaleCommon Stock | 6,250 | $35.25 | $220,315.63 |
DisclosureSEC source: 0001209191-17-026672 · doc4.xml · nonDerivative · entry 1 McClellan Stephen R · CIK 0001447779 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,599 F1 · price: This transaction was executed in multiple trades at prices ranging from $35.01 to $35.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The shares were sold pursuant to a written trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 20:27 UTC |
Wessel MichaelDirector
|
GrantRestricted Stock Units · Derivative | 992 | $35.28 | $34,997.76 |
DisclosureSEC source: 0001209191-17-025660 · doc4.xml · derivative · entry 1 Wessel Michael · CIK 0001346244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,109 Underlying: Common Stock · 992 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 20:24 UTC |
WEIDEMEYER THOMAS HDirector
|
GrantRestricted Stock Units · Derivative | 992 | $35.28 | $34,997.76 |
DisclosureSEC source: 0001209191-17-025652 · doc4.xml · derivative · entry 1 WEIDEMEYER THOMAS H · CIK 0001227740 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,109 Underlying: Common Stock · 992 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 20:18 UTC |
Morell Michael JDirector
|
GrantRestricted Stock Units · Derivative | 992 | $35.28 | $34,997.76 |
DisclosureSEC source: 0001209191-17-025633 · doc4.xml · derivative · entry 1 Morell Michael J · CIK 0001596480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,477 Underlying: Common Stock · 992 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 20:22 UTC |
STREETER STEPHANIE ADirector
|
GrantRestricted Stock Units · Derivative | 992 | $35.28 | $34,997.76 |
DisclosureSEC source: 0001209191-17-025645 · doc4.xml · derivative · entry 1 STREETER STEPHANIE A · CIK 0001021762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,863 Underlying: Common Stock · 992 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 20:20 UTC |
PALMORE RODERICK ADirector
|
GrantRestricted Stock Units · Derivative | 992 | $35.28 | $34,997.76 |
DisclosureSEC source: 0001209191-17-025636 · doc4.xml · derivative · entry 1 PALMORE RODERICK A · CIK 0001218964 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,685 Underlying: Common Stock · 992 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 20:16 UTC |
MCGLADE JOHN EDirector
|
GrantRestricted Stock Units · Derivative | 992 | $35.28 | $34,997.76 |
DisclosureSEC source: 0001209191-17-025627 · doc4.xml · derivative · entry 1 MCGLADE JOHN E · CIK 0001265896 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,746 Underlying: Common Stock · 992 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 20:14 UTC |
MCCOLLOUGH W ALANDirector
|
GrantRestricted Stock Units · Derivative | 992 | $35.28 | $34,997.76 |
DisclosureSEC source: 0001209191-17-025621 · doc4.xml · derivative · entry 1 MCCOLLOUGH W ALAN · CIK 0001209891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,109 Underlying: Common Stock · 992 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 20:13 UTC |
KOELLNER LAURETTE TDirector
|
GrantRestricted Stock Units · Derivative | 886 | $35.28 | $31,258.08 |
DisclosureSEC source: 0001209191-17-025612 · doc4.xml · derivative · entry 2 KOELLNER LAURETTE T · CIK 0001182054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,963 Underlying: Common Stock · 886 shares Expires not disclosed F4 · security: RSUs accrued, pursuant to an election by the reporting person, to the Retainer Deferral Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F5 · balance_after: Total RSUs accrued to the Retainer Deferral Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 20:13 UTC |
KOELLNER LAURETTE TDirector
|
GrantRestricted Stock Units · Derivative | 992 | $35.28 | $34,997.76 |
DisclosureSEC source: 0001209191-17-025612 · doc4.xml · derivative · entry 1 KOELLNER LAURETTE T · CIK 0001182054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,371 Underlying: Common Stock · 992 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 20:11 UTC |
HELLMAN PETER SDirector
|
GrantRestricted Stock Units · Derivative | 992 | $35.28 | $34,997.76 |
DisclosureSEC source: 0001209191-17-025605 · doc4.xml · derivative · entry 1 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,567 Underlying: Common Stock · 992 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 20:10 UTC |
Geissler WernerDirector
|
GrantRestricted Stock Units · Derivative | 992 | $35.28 | $34,997.76 |
DisclosureSEC source: 0001209191-17-025596 · doc4.xml · derivative · entry 1 Geissler Werner · CIK 0001402226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,291 Underlying: Common Stock · 992 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 20:08 UTC |
FIRESTONE JAMES ADirector
|
GrantRestricted Stock Units · Derivative | 992 | $35.28 | $34,997.76 |
DisclosureSEC source: 0001209191-17-025585 · doc4.xml · derivative · entry 1 FIRESTONE JAMES A · CIK 0001207838 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,109 Underlying: Common Stock · 992 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 20:07 UTC |
CONATY WILLIAM JDirector
|
GrantRestricted Stock Units · Derivative | 992 | $35.28 | $34,997.76 |
DisclosureSEC source: 0001209191-17-025580 · doc4.xml · derivative · entry 1 CONATY WILLIAM J · CIK 0001233156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,819 Underlying: Common Stock · 992 shares Expires not disclosed F1 · security: Restricted Stock Units ("RSU"), each equivalent to a share of the Common Stock of the Company and payable only in Common Stock, awarded pursuant to the Company's Outside Directors' Equity Participation Plan, as amended (the "Plan"), and accrued to the Equity Participation Account of the reporting person in accordance with the Plan. F2 · derivative.exercise_price: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.exercise_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F2 · derivative.expiration_date: Each RSU was valued at the fair market value (the closing market price) on the Transaction Date. Each RSU will be converted to a share of Common Stock on the fifth business day of the calendar quarter following the quarter of the Director's separation from Board service. F3 · balance_after: Total RSUs accrued to the Equity Participation Account of the reporting person as of the date of this statement. Read SEC document |
| March 15, 2017 Filed Mar 16, 2017 20:38 UTC |
NOECHEL RICHARD JSVP, Business Transformation
|
Exercise / conversion2008 Plan Option · Derivative | 13,963 | $0.00 Strike: $12.94 | $0.00 |
DisclosureSEC source: 0001209191-17-021107 · doc4.xml · derivative · entry 4 NOECHEL RICHARD J · CIK 0001250211 · SVP, Business Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,963 shares Expires 2022-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Non-Qualified Stock Option in respect of shares of common stock granted under the 2008 Performance Plan. F3 · derivative.exercise_date: The option vested and became exercisable in 25% increments over four years commencing one year after the date of grant (February 27, 2012). Read SEC document |
| March 15, 2017 Filed Mar 16, 2017 20:38 UTC |
NOECHEL RICHARD JSVP, Business Transformation
|
SaleCommon Stock | 4,721 | $36.89 | $174,136.92 |
DisclosureSEC source: 0001209191-17-021107 · doc4.xml · nonDerivative · entry 3 NOECHEL RICHARD J · CIK 0001250211 · SVP, Business Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,889 F1 · price: This transaction was executed in multiple trades at prices ranging from $36.88 to $36.905. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 15, 2017 Filed Mar 16, 2017 20:38 UTC |
NOECHEL RICHARD JSVP, Business Transformation
|
Tax withholdingCommon Stock | 9,242 | $36.89 | $340,896.72 |
DisclosureSEC source: 0001209191-17-021107 · doc4.xml · nonDerivative · entry 2 NOECHEL RICHARD J · CIK 0001250211 · SVP, Business Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,610 F1 · price: This transaction was executed in multiple trades at prices ranging from $36.88 to $36.905. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 15, 2017 Filed Mar 16, 2017 20:38 UTC |
NOECHEL RICHARD JSVP, Business Transformation
|
Exercise / conversionCommon Stock | 13,963 | $12.94 | $180,681.22 |
DisclosureSEC source: 0001209191-17-021107 · doc4.xml · nonDerivative · entry 1 NOECHEL RICHARD J · CIK 0001250211 · SVP, Business Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,852 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:58 UTC |
Delaney Christopher RPresident, Asia-Pacific Region
|
Grant2013 Plan Option · Derivative | 34,147 | $0.00 Strike: $35.26 | $0.00 |
DisclosureSEC source: 0001209191-17-015949 · doc4.xml · derivative · entry 2 Delaney Christopher R · CIK 0001663064 · President, Asia-Pacific Region 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,147 Underlying: Common Stock · 34,147 shares Expires 2027-02-27 F2 · security: Non-Qualified Stock Option in respect of shares of common stock granted under the 2013 Performance Plan. F3 · derivative.exercise_date: The option vests and becomes exercisable in 25% increments over four years commencing one year after the date of grant. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:58 UTC |
Delaney Christopher RPresident, Asia-Pacific Region
|
Grant2013 Plan Performance Shares · Derivative | 7,799 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015949 · doc4.xml · derivative · entry 1 Delaney Christopher R · CIK 0001663064 · President, Asia-Pacific Region 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,799 Underlying: Common Stock · 7,799 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_price: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.expiration_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:16 UTC |
Zekoski JosephSr VP Opers & Chief Tech Ofcr
|
Grant2013 Plan Option · Derivative | 18,625 | $0.00 Strike: $35.26 | $0.00 |
DisclosureSEC source: 0001209191-17-016002 · doc4.xml · derivative · entry 2 Zekoski Joseph · CIK 0001634342 · Sr VP Opers & Chief Tech Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,625 Underlying: Common Stock · 18,625 shares Expires 2027-02-27 F2 · security: Non-Qualified Stock Option in respect of shares of common stock granted under the 2013 Performance Plan. F3 · derivative.exercise_date: The option vests and becomes exercisable in 25% increments over four years commencing one year after the date of grant. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:16 UTC |
Zekoski JosephSr VP Opers & Chief Tech Ofcr
|
Grant2013 Plan Performance Shares · Derivative | 4,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016002 · doc4.xml · derivative · entry 1 Zekoski Joseph · CIK 0001634342 · Sr VP Opers & Chief Tech Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,254 Underlying: Common Stock · 4,254 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_price: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.expiration_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:15 UTC |
Thompson Laura KExec VP & Chief Fin Ofcr
|
Grant2013 Plan Option · Derivative | 58,981 | $0.00 Strike: $35.26 | $0.00 |
DisclosureSEC source: 0001209191-17-015998 · doc4.xml · derivative · entry 2 Thompson Laura K · CIK 0001589405 · Exec VP & Chief Fin Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,981 Underlying: Common Stock · 58,981 shares Expires 2027-02-27 F2 · security: Non-Qualified Stock Option in respect of shares of common stock granted under the 2013 Performance Plan. F3 · derivative.exercise_date: The option vests and becomes exercisable in 25% increments over four years commencing one year after the date of grant. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:15 UTC |
Thompson Laura KExec VP & Chief Fin Ofcr
|
Grant2013 Plan Performance Shares · Derivative | 13,471 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015998 · doc4.xml · derivative · entry 1 Thompson Laura K · CIK 0001589405 · Exec VP & Chief Fin Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,471 Underlying: Common Stock · 13,471 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_price: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.expiration_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:13 UTC |
Scocos Evan MVice President and Controller
|
Grant2013 Plan Option · Derivative | 7,822 | $0.00 Strike: $35.26 | $0.00 |
DisclosureSEC source: 0001209191-17-015992 · doc4.xml · derivative · entry 2 Scocos Evan M · CIK 0001674989 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,822 Underlying: Common Stock · 7,822 shares Expires 2027-02-27 F2 · security: Non-Qualified Stock Option in respect of shares of common stock granted under the 2013 Performance Plan. F3 · derivative.exercise_date: The option vests and becomes exercisable in 25% increments over four years commencing one year after the date of grant. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:13 UTC |
Scocos Evan MVice President and Controller
|
Grant2013 Plan Performance Shares · Derivative | 1,786 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015992 · doc4.xml · derivative · entry 1 Scocos Evan M · CIK 0001674989 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,786 Underlying: Common Stock · 1,786 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_price: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.expiration_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:12 UTC |
NOECHEL RICHARD JSVP, Business Transformation
|
Grant2013 Plan Option · Derivative | 17,384 | $0.00 Strike: $35.26 | $0.00 |
DisclosureSEC source: 0001209191-17-015988 · doc4.xml · derivative · entry 2 NOECHEL RICHARD J · CIK 0001250211 · SVP, Business Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 Underlying: Common Stock · 17,384 shares Expires 2027-02-27 F2 · security: Non-Qualified Stock Option in respect of shares of common stock granted under the 2013 Performance Plan. F3 · derivative.exercise_date: The option vests and becomes exercisable in 25% increments over four years commencing one year after the date of grant. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:12 UTC |
NOECHEL RICHARD JSVP, Business Transformation
|
Grant2013 Plan Performance Shares · Derivative | 3,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015988 · doc4.xml · derivative · entry 1 NOECHEL RICHARD J · CIK 0001250211 · SVP, Business Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,970 Underlying: Common Stock · 3,970 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_price: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.expiration_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:10 UTC |
Lucas JohnSr VP, Global Human Resources
|
Grant2013 Plan Option · Derivative | 39,362 | $0.00 Strike: $35.26 | $0.00 |
DisclosureSEC source: 0001209191-17-015977 · doc4.xml · derivative · entry 2 Lucas John · CIK 0001632147 · Sr VP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,362 Underlying: Common Stock · 39,362 shares Expires 2027-02-27 F2 · security: Non-Qualified Stock Option in respect of shares of common stock granted under the 2013 Performance Plan. F3 · derivative.exercise_date: The option vests and becomes exercisable in 25% increments over four years commencing one year after the date of grant. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:10 UTC |
Lucas JohnSr VP, Global Human Resources
|
Grant2013 Plan Performance Shares · Derivative | 8,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015977 · doc4.xml · derivative · entry 1 Lucas John · CIK 0001632147 · Sr VP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,990 Underlying: Common Stock · 8,990 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_price: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.expiration_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:11 UTC |
McClellan Stephen RPresident, Americas
|
Grant2013 Plan Option · Derivative | 53,394 | $0.00 Strike: $35.26 | $0.00 |
DisclosureSEC source: 0001209191-17-015982 · doc4.xml · derivative · entry 2 McClellan Stephen R · CIK 0001447779 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,394 Underlying: Common Stock · 53,394 shares Expires 2027-02-27 F2 · security: Non-Qualified Stock Option in respect of shares of common stock granted under the 2013 Performance Plan. F3 · derivative.exercise_date: The option vests and becomes exercisable in 25% increments over four years commencing one year after the date of grant. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:11 UTC |
McClellan Stephen RPresident, Americas
|
Grant2013 Plan Performance Shares · Derivative | 12,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015982 · doc4.xml · derivative · entry 1 McClellan Stephen R · CIK 0001447779 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,195 Underlying: Common Stock · 12,195 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_price: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.expiration_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:09 UTC |
KRAMER RICHARD JDirector · Chairman of the Bd, CEO & Pres
|
Grant2013 Plan Option · Derivative | 264,486 | $0.00 Strike: $35.26 | $0.00 |
DisclosureSEC source: 0001209191-17-015975 · doc4.xml · derivative · entry 2 KRAMER RICHARD J · CIK 0001201067 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,486 Underlying: Common Stock · 264,486 shares Expires 2027-02-27 F2 · security: Non-Qualified Stock Option in respect of shares of common stock granted under the 2013 Performance Plan. F3 · derivative.exercise_date: The option vests and becomes exercisable in 25% increments over four years commencing one year after the date of grant. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:09 UTC |
KRAMER RICHARD JDirector · Chairman of the Bd, CEO & Pres
|
Grant2013 Plan Performance Shares · Derivative | 60,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015975 · doc4.xml · derivative · entry 1 KRAMER RICHARD J · CIK 0001201067 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,408 Underlying: Common Stock · 60,408 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_price: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.expiration_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:08 UTC |
King Scott HSr VP, Strategy & Bus Develop
|
Grant2013 Plan Option · Derivative | 16,763 | $0.00 Strike: $35.26 | $0.00 |
DisclosureSEC source: 0001209191-17-015973 · doc4.xml · derivative · entry 2 King Scott H · CIK 0001643064 · Sr VP, Strategy & Bus Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,763 Underlying: Common Stock · 16,763 shares Expires 2027-02-27 F2 · security: Non-Qualified Stock Option in respect of shares of common stock granted under the 2013 Performance Plan. F3 · derivative.exercise_date: The option vests and becomes exercisable in 25% increments over four years commencing one year after the date of grant. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:08 UTC |
King Scott HSr VP, Strategy & Bus Develop
|
Grant2013 Plan Performance Shares · Derivative | 3,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015973 · doc4.xml · derivative · entry 1 King Scott H · CIK 0001643064 · Sr VP, Strategy & Bus Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,828 Underlying: Common Stock · 3,828 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_price: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.expiration_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:07 UTC |
Kihn Jean ClaudePresident, EMEA
|
Grant2013 Plan Option · Derivative | 34,395 | $0.00 Strike: $35.26 | $0.00 |
DisclosureSEC source: 0001209191-17-015970 · doc4.xml · derivative · entry 2 Kihn Jean Claude · CIK 0001423110 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,395 Underlying: Common Stock · 34,395 shares Expires 2027-02-27 F2 · security: Non-Qualified Stock Option in respect of shares of common stock granted under the 2013 Performance Plan. F3 · derivative.exercise_date: The option vests and becomes exercisable in 25% increments over four years commencing one year after the date of grant. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:07 UTC |
Kihn Jean ClaudePresident, EMEA
|
Grant2013 Plan Performance Shares · Derivative | 7,855 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015970 · doc4.xml · derivative · entry 1 Kihn Jean Claude · CIK 0001423110 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,855 Underlying: Common Stock · 7,855 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_price: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.expiration_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:06 UTC |
Kellam RichardSr VP Global Sales & Marketing
|
Grant2013 Plan Option · Derivative | 26,324 | $0.00 Strike: $35.26 | $0.00 |
DisclosureSEC source: 0001209191-17-015968 · doc4.xml · derivative · entry 2 Kellam Richard · CIK 0001620812 · Sr VP Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,324 Underlying: Common Stock · 26,324 shares Expires 2027-02-27 F2 · security: Non-Qualified Stock Option in respect of shares of common stock granted under the 2013 Performance Plan. F3 · derivative.exercise_date: The option vests and becomes exercisable in 25% increments over four years commencing one year after the date of grant. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:06 UTC |
Kellam RichardSr VP Global Sales & Marketing
|
Grant2013 Plan Performance Shares · Derivative | 6,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015968 · doc4.xml · derivative · entry 1 Kellam Richard · CIK 0001620812 · Sr VP Global Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,012 Underlying: Common Stock · 6,012 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_price: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.expiration_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:04 UTC |
Fitzhenry PaulSr VP, Global Communications
|
Grant2013 Plan Option · Derivative | 10,927 | $0.00 Strike: $35.26 | $0.00 |
DisclosureSEC source: 0001209191-17-015965 · doc4.xml · derivative · entry 2 Fitzhenry Paul · CIK 0001559617 · Sr VP, Global Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,927 Underlying: Common Stock · 10,927 shares Expires 2027-02-27 F2 · security: Non-Qualified Stock Option in respect of shares of common stock granted under the 2013 Performance Plan. F3 · derivative.exercise_date: The option vests and becomes exercisable in 25% increments over four years commencing one year after the date of grant. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:04 UTC |
Fitzhenry PaulSr VP, Global Communications
|
Grant2013 Plan Performance Shares · Derivative | 2,495 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015965 · doc4.xml · derivative · entry 1 Fitzhenry Paul · CIK 0001559617 · Sr VP, Global Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,495 Underlying: Common Stock · 2,495 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_price: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.expiration_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:56 UTC |
BIALOSKY DAVID LSr Vice Pres, Gen Cnsl & Sec'y
|
Grant2013 Plan Option · Derivative | 40,355 | $0.00 Strike: $35.26 | $0.00 |
DisclosureSEC source: 0001209191-17-015946 · doc4.xml · derivative · entry 2 BIALOSKY DAVID L · CIK 0001275932 · Sr Vice Pres, Gen Cnsl & Sec'y 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,355 Underlying: Common Stock · 40,355 shares Expires 2027-02-27 F2 · security: Non-Qualified Stock Option in respect of shares of common stock granted under the 2013 Performance Plan. F3 · derivative.exercise_date: The option vests and becomes exercisable in 25% increments over four years commencing one year after the date of grant. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:56 UTC |
BIALOSKY DAVID LSr Vice Pres, Gen Cnsl & Sec'y
|
Grant2013 Plan Performance Shares · Derivative | 9,217 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015946 · doc4.xml · derivative · entry 1 BIALOSKY DAVID L · CIK 0001275932 · Sr Vice Pres, Gen Cnsl & Sec'y 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,217 Underlying: Common Stock · 9,217 shares Expires not disclosed F1 · security: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_price: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.exercise_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. F1 · derivative.expiration_date: Performance Share Unit grant under the 2013 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2020. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 4, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2019, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2019. Read SEC document |
| February 24, 2017 Filed Apr 5, 2017 20:31 UTC |
Zekoski JosephSr VP Opers & Chief Tech Ofcr
|
Exercise / conversion2013 Plan Restricted Stock Units · Derivative | 608 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-025667 · doc4.xml · derivative · entry 4 Zekoski Joseph · CIK 0001634342 · Sr VP Opers & Chief Tech Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 608 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February 2014. F3 · derivative.exercise_date: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February 2014. F3 · derivative.expiration_date: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February 2014. Read SEC document |
| February 24, 2017 Filed Apr 5, 2017 20:31 UTC |
Zekoski JosephSr VP Opers & Chief Tech Ofcr
|
Tax withholdingCommon Stock | 203 | $35.36 | $7,178.08 |
DisclosureSEC source: 0001209191-17-025667 · doc4.xml · nonDerivative · entry 2 Zekoski Joseph · CIK 0001634342 · Sr VP Opers & Chief Tech Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,875 F1 · kind: Shares of common stock withheld by the issuer for the payment of withholding taxes. Read SEC document |
| February 24, 2017 Filed Apr 5, 2017 20:31 UTC |
Zekoski JosephSr VP Opers & Chief Tech Ofcr
|
Exercise / conversionCommon Stock | 608 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-025667 · doc4.xml · nonDerivative · entry 1 Zekoski Joseph · CIK 0001634342 · Sr VP Opers & Chief Tech Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2017 Filed Apr 5, 2017 20:28 UTC |
Scocos Evan MVice President and Controller
|
Exercise / conversion2013 Plan Restricted Stock Units · Derivative | 358 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-025664 · doc4.xml · derivative · entry 4 Scocos Evan M · CIK 0001674989 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 358 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February 2014. F3 · derivative.exercise_date: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February 2014. F3 · derivative.expiration_date: This Form 4 reports the vesting and conversion of Restricted Stock Units ("RSUs") granted in February 2014. Read SEC document |
| February 24, 2017 Filed Apr 5, 2017 20:28 UTC |
Scocos Evan MVice President and Controller
|
Tax withholdingCommon Stock | 119 | $35.36 | $4,207.84 |
DisclosureSEC source: 0001209191-17-025664 · doc4.xml · nonDerivative · entry 2 Scocos Evan M · CIK 0001674989 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,071 F1 · kind: Shares of common stock withheld by the issuer for the payment of withholding taxes. Read SEC document |
| February 24, 2017 Filed Apr 5, 2017 20:28 UTC |
Scocos Evan MVice President and Controller
|
Exercise / conversionCommon Stock | 358 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-025664 · doc4.xml · nonDerivative · entry 1 Scocos Evan M · CIK 0001674989 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.